Key facts
- It has raised $250K.
- Notable investors include UK Research and Innovation, Accelerate Cambridge, Carbon13, Enterprise Hub - Royal Academy of Engineering, Science Creates — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for LeafyColl
- ·The full record, as it builds
Funding rounds
No funding rounds for LeafyColl are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About LeafyColl
Developer of plant-made collagen for beauty and wellness, designed to provide minimally invasive products for women's urinary incontinence. The company, pioneering the sustainable production of bio-identical collagen and other high-value specialty proteins and fortified crops, allows scalable, plant-based production of ingredients for food, beverages, nutraceuticals, regenerative medicine, beauty, and alternative meat products, enabling users to get cost-effective services as per their needs.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Cambridge, United Kingdom
- Founded
- 2023
- Employees
- 3
- Website
- leafycoll.com/
- Ownership
- Privately Held (backing)
LeafyColl doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LeafyColl shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LeafyColl in its N-PORT filings yet. We sweep new filings monthly.